Position in EDIT
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$172,413
+$39,459 QoQ
Shares Held
69,803
+7.6% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.08309098462816784.ToString("F0")%
Shared 0.ToString("F0")%
None 99.91690901537183.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LPL Financial LLC holds $467,195,563 across 201 Biotechnology names. EDIT ranks #138 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
268,062 | $119,700,405 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
63,987 | $49,438,915 | |
| 3 | INSM |
INSMED Inc
|
138,281 | $22,611,709 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
67,637 | $22,379,054 | |
| 5 | EXEL |
Exelixis, Inc.
|
399,612 | $17,139,358 | |
| 6 | ARGX |
Argenx SE
|
23,247 | $16,976,121 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
194,304 | $12,557,867 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
378,656 | $10,488,771 |
All Filings in EDIT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $172,413 | 69,803 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $132,954 | 64,856 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $143,703 | 41,413 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $96,646 | 43,930 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $53,923 | 46,486 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $67,726 | 53,328 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $223,767 | 65,621 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $365,754 | 78,320 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $530,351 | 71,476 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $776,748 | 76,678 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $619,881 | 79,472 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $630,064 | 76,557 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $452,914 | 62,471 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $435,082 | 49,051 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $535,083 | 43,716 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $529,510 | 44,760 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $721,409 | 37,929 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,156,836 | 43,572 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,161,958 | 52,628 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,765,957 | 48,834 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,726,430 | 64,915 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,186,268 | 59,710 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,610,812 | 57,406 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,554,783 | 52,562 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $491,070 | 24,764 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||